Dr Forrester suggested that the development to state that the donations had been tested for ALT commercial companies, could lead haemophilia clinicians and SNBTS directors to put pressure on the SHHD to agree to the introduction of surrogate screening.
Chronology Information
Date:
Chapter/issue
Hepatitis C Surrogate Screening
Key Person(s)
Dr John M Forrester